PLUS THERAPEUTICS, INC. — Director's Dealing 2023

Nov 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2023-11-15

Reporting Person: Lenk Robert P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-15	Common Stock	P	1000	$1.77	Acquired	24160	Direct
2023-11-16	Common Stock	P	1000	$1.95	Acquired	25160	Direct